Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042

(2019) Francisco Hermida-Prado et al.   Journal of Clinical Medicine

Ca 2+ signaling and Src-kinases-controlled cellular functions

(2018) Estefanía Anguita et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

(2018) Yun Liu et al.   CANCER RESEARCH

Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib

(2018) Liwei Lang et al.   Journal of Hematology & Oncology

Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells

(2018) Yuri Namba et al.   Frontiers in Oncology

Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients

(2016) Antonia K. Roseweir et al.   BMC CANCER

ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma

(2016) Lu Xu et al.   TUMOR BIOLOGY

Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells

(2015) Shota Tanaka et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M

(2015) Song Zhao et al.   BMC CANCER

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

SRC inhibition represents a potential therapeutic strategy in liposarcoma

(2015) Elisabeth Sievers et al.   INTERNATIONAL JOURNAL OF CANCER

CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases

(2015) C Leroy et al.   ONCOGENE

Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patients

(2015) RAN ZHAO et al.   Oncology Letters

Surgical and Locoregional Therapy of HCC: TACE

(2015) Masakatsu Tsurusaki et al.   Liver Cancer

Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors

(2014) Hideki Yamaguchi et al.   CANCER SCIENCE

Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1

(2014) Yang Bu et al.   PLoS One

Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia

(2013) Shukui Qin et al.   JOURNAL OF CLINICAL ONCOLOGY